Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · IEX Real-Time Price · USD
0.640
-0.025 (-3.77%)
Apr 23, 2024, 1:41 PM EDT - Market open
Petros Pharmaceuticals Stock Forecast
PTPI's stock price has decreased by -81.51% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PTPI stock has a target of 4.00, which predicts an increase of 525.00% from the current stock price of 0.64.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 8, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for PTPI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +525.00% | Dec 8, 2023 |
Financial Forecast
Revenue This Year
5.78M
from 5.82M
Decreased by -0.76%
Revenue Next Year
5.78M
from 5.78M
Increased by 0.09%
EPS This Year
-6.13
from -6.35
EPS Next Year
-4.34
from -6.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.9M | 6.0M | 11.8M |
| Avg | 5.8M | 5.8M | 11.5M |
| Low | 5.6M | 5.6M | 11.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.2% | 3.0% | 103.8% |
| Avg | -0.8% | 0.1% | 98.0% |
| Low | -4.6% | -3.8% | 90.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -6.31 | -4.46 | -3.30 |
| Avg | -6.13 | -4.34 | -3.20 |
| Low | -5.89 | -4.17 | -3.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.